Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) Short Interest Update

Biodexa Pharmaceuticals Plc (NASDAQ:BDRX) was the recipient of a large decrease in short interest in the month of December. As of December 15th, there was short interest totalling 27,800 shares, a decrease of 46.5% from the November 30th total of 52,000 shares. Based on an average daily trading volume, of 276,600 shares, the days-to-cover ratio is presently 0.1 days.

Biodexa Pharmaceuticals Stock Down 8.7 %

Shares of Biodexa Pharmaceuticals stock traded down $0.41 during trading hours on Friday, reaching $4.29. 18,151 shares of the stock traded hands, compared to its average volume of 144,341. Biodexa Pharmaceuticals has a one year low of $3.50 and a one year high of $74.00. The business’s 50 day moving average is $5.05.

About Biodexa Pharmaceuticals

Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of Type 1 diabetes and rare/orphan cancers of the brain. Its lead product candidate Tolimidone, a selective activator of the lyn kinase enzyme, currently under Phase II studies for the treatment of Type 1 diabetes.